SandeepSoniMD
Pediatric Hematology & Oncology • Palo Alto, CAAssociate Professor, Pediatrics, Ohio State University College of Medicine
Are you Dr. Soni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000Fax+1 614-722-3699
Summary
- Dr. Sandeep Soni, MD is a pediatric hematologist/oncologist in Palo Alto, California. He is currently licensed to practice medicine in California, Ohio, and Kentucky. He is affiliated with Lucile Packard Children's Hospital Stanford and is an Associate Professor at Ohio State University College of Medicine.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 2002 - 2004
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2000 - 2002- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Maulana Azad Medical CollegeClass of 1988
Certifications & Licensure
CA State Medical License 2017 - 2026
OH State Medical License 2006 - 2018
KY State Medical License 2003 - 2007
TX State Medical License 2002 - 2004
WA State Medical License 2002 - 2004- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. Start of enrollment: 2008 Sep 01
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
- Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. Start of enrollment: 2010 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- 510 citationsCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.Haydar Frangoul, David Altshuler, M Domenica Cappellini, Yi-Shan Chen, Jennifer Domm
The New England Journal of Medicine. 2021-01-21 - 21 citationsGene therapies for transfusion dependent β-thalassemia: Current status and critical criteria for success.Sandeep Soni
American Journal of Hematology. 2020-06-19 - 8 citationsA Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's ...Stella M. Davies, Robert Iannone, Todd A. Alonzo, Yi-Cheng Wang, Robert B. Gerbing
Biology of Blood and Marrow Transplantation. 2020-04-01
